Morningstar

Charles River Laboratories International Inc CRL

Morningstar Rating
Unlock
Stock XNYS Rating as of
$192.90 −1.18 (0.61%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
CRL is trading at a 51% premium.
Price
$192.90
Fair Value
$518.00
Uncertainty
Medium
1-Star Price
$851.00
5-Star Price
$435.00
Economic Moat
Dbbrzp
Capital Allocation
Zlsxmkk

Bulls Say, Bears Say

Bulls

Charles River’s reputation for quality and scientific expertise supports its leading position in the research model and preclinical trial markets.

Bears

Charles River does not have a long-term advantage in drug discovery, as we believe that will remain the core competency of biotechnology and pharmaceutical companies.

Show More

News

View All

Trading Information

Previous Close Price
$194.08
Day Range
$189.33–194.82
52-Week Range
$161.65–275.00
Bid/Ask
$168.83 / $228.99
Market Cap
$9.96 Bil
Volume/Avg
675,063 / 693,682

Key Statistics

Price/Earnings (Normalized)
18.82
Price/Sales
2.44
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
0.19%

Company Profile

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
21,400
Website
https://www.criver.com

Competitors

Valuation

View More
Metric
CRL
FTRE
LH
Price/Earnings (Normalized)
 18.8222.2415.31
Price/Book Value
 2.671.172.29
Price/Sales
 2.440.591.50
Price/Cash Flow
 12.97—11.43
Price/Earnings
CRL
FTRE
LH

Financial Strength

Metric
CRL
FTRE
LH
Quick Ratio
 0.991.020.62
Current Ratio
 1.581.190.88
Interest Coverage
 4.94−0.504.39
Quick Ratio
CRL
FTRE
LH

Profitability

Metric
CRL
FTRE
LH
Return on Assets (Normalized)
 6.68%0.74%5.39%
Return on Equity (Normalized)
 15.13%1.86%11.25%
Return on Invested Capital (Normalized)
 9.69%4.58%7.35%
Return on Assets
CRL
FTRE
LH

Diagnostics & Research Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
XzqywhhxHcs$234.1 Bil
 Danaher Corp
DHR
YjrdwlqbMbdtzx$197.8 Bil
 IQVIA Holdings Inc
IQV
TdlfjpbhYtklzy$42.2 Bil
 Agilent Technologies Inc
A
GqqyvlxcvrBbtrs$42.1 Bil
 IDEXX Laboratories Inc
IDXX
BhbwqllqwKmxk$40.0 Bil
 Mettler-Toledo International Inc
MTD
JcpzjjkbdTnslt$31.8 Bil
 Icon PLC
ICLR
LfzgzsrsSmmwz$24.4 Bil
 Illumina Inc
ILMN
YpnjpsfcVylmyyb$22.1 Bil
 Waters Corp
WAT
DbhrshgfzrVgty$21.1 Bil
 Labcorp Holdings Inc
LH
PmcjtstvpKgrpgw$18.4 Bil

Sponsor Center